Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Scientific Reports|May 5, 2022
Spatial maps and oscillations in the healthy hippocampus of Octodon degus, a natural model of sporadic Alzheimer's diseaseMatias Mugnaini, Diana Polania, Yannina Diaz, et al.
Neuropharmacology|May 25, 2018
Repurposing available drugs for neurodevelopmental disorders: The fragile X experienceMichael R Tranfaglia, Clare Thibodeaux, Daniel J Mason, et al.
Brain : a Journal of Neurology|July 1, 2021
Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome miceMichael J Hurley, Robert M J Deacon, A W Edith Chan, et al.
Acta Neuropathologica Communications|December 18, 2022
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer's diseaseZhiqun Tan, B Maximiliano Garduño, Pedro Fernández Aburto, et al.
Neuromolecular Medicine|January 24, 2015
NNZ-2566, a novel analog of (1-3) IGF-1, as a potential therapeutic agent for fragile X syndromeRobert M J Deacon, Larry Glass, Mike Snape, et al.
Frontiers in Behavioral Neuroscience|July 12, 2019
Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X SyndromePatricia Cogram, Robert M J Deacon, Jennifer L Warner-Schmidt, et al.
Scientific Reports|October 23, 2020
Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X micePatricia Cogram, Daniel L Alkon, David Crockford, et al.
Molecular and Cellular Biology|July 16, 2004
Rap1 regulates the formation of E-cadherin-based cell-cell contactsCatherine Hogan, Norberto Serpente, Patricia Cogram, et al.
Frontiers in Neuroscience|December 5, 2022
The inhibition of NCS-1 binding to Ric8a rescues fragile X syndrome mice model phenotypesPatricia Cogram, Luis C Fernández-Beltrán, María José Casarejos, et al.
Pageof 3